Last 15.70 TWD
Change Today 0.00 / 0.00%
Volume 3.1M
1731 On Other Exchanges
As of 2:36 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

maywufa company ltd (1731) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/24/13 - 18.25
52 Week Low
08/28/13 - 14.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MAYWUFA COMPANY LTD (1731)

Related News

No related news articles were found.

maywufa company ltd (1731) Related Businessweek News

No Related Businessweek News Found

maywufa company ltd (1731) Details

Maywufa Company Limited engages in the research and development, manufacture, and marketing of oriental haircare and skincare products under the Maywufa name in Taiwan. The company operates through four divisions: Hair Care & Skincare, Pharmacy Franchise/GP&AH, Kaisers Medical, and Institutional Hospitals. The Hair Care & Skincare division offers colorant for gary hair coverage, hair colorant, shampoo, and shower series products. The Pharmacy Franchise/GP&AH division operates pharmacy franchise system, which is specialized in the dispensing of prescription drugs with approximately 200 pharmacy stores; and as an agent for French cosmeceutical brands of Mustela and Noviderm, as well as provides sales teams for pharmaceutical products with a range coverage of approximately 5000 drug stores, GPs, and hospitals in Taiwan. The Kaisers Medical division distributes anti-diabetics products; and sells nutraceutical products, such as PhytoSlim for less easy formation of body fat, Nattokinase Extract capsule and Red Yeast Rice product for lipid lowering, and EnerCharge for boosting energy. This division also operates as an agent for Japanese cosmetic brand, Mariannebolle; and for European pharmaceutical companies, such as Ever Neuro, Novartis, BioEqual, etc. The Institutional Hospitals division engages in the sale and marketing of pharmaceutical products of various principals and products, including Bristol Meyers-Squibb’s Maxipime, Ever Neuro’s Cerebrolysin, and Toa’s Bio-Three H for gastrointestinal tract care, as well as PG2 for the for therapy for alleviating cancer-related fatigue and Epilen for the treatment of epilepsy to various institutional hospitals. Maywufa Company Limited was founded in 1976 and is based in Taipei, Taiwan.

Founded in 1976

maywufa company ltd (1731) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

maywufa company ltd (1731) Key Developments

Maywufa Company Ltd. Proposes Amendments to Articles of Incorporation

Maywufa Company Ltd. announced that at its annual general meeting to be held on June 18, 2014, the shareholders proposed the amendments to the Articles of Incorporation.

Maywufa Company Ltd. Proposes Cash Dividends

Maywufa Company Ltd. proposed cash dividends of TWD 0.4 per share.

Maywufa Company, Ltd., Annual General Meeting, Jun 21, 2013

Maywufa Company, Ltd., Annual General Meeting, Jun 21, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1731:TT 15.70 TWD 0.00

1731 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1731.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1731 Industry Range
Price/Earnings 32.5x
Price/Sales 1.4x
Price/Book 1.2x
Price/Cash Flow 32.5x
TEV/Sales 0.8x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAYWUFA COMPANY LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at